Besonderhede van voorbeeld: 1139608679485238554

English

AlloCSC-01 will compete against a variety of cell therapy treatments in development for acute myocardial infarction, including products under development by Pharmicell, Caladrius, Athersys, Mesoblast and Capricor, as well as treatments using other therapeutic modalities such as tissue engineering and gene therapy approaches.

Dutch

AlloCSC-01 zal concurreren tegen verschillende celtherapie behandelingen in ontwikkeling tegen acuut myocardifarct, zoals producten die worden ontwikkeld door Pharmicell, Caladrius, Athersys, Mesoblast en Capricor, evenals behandelingen die andere therapeutische modaliteiten gebruiken zoals weefseltechnologie en gentherapie.